Enable Biosciences Receives $3M Phase IIB SBIR Award from NIDDK for Advanced T1D Testing Technology

/PRNewswire/ -- Enable Biosciences Inc., a leader in diagnostic technologies, is elated to announce its receipt of a Phase IIB Small Business Innovation...

Related Keywords

,Peter Robinson ,Jason Tsai ,Small Business Innovation Research ,Laboratory Analytical Validation ,Biosciences Inc ,National Institute Of Diabetes ,Prnewswire Enable Biosciences Inc ,Business Innovation Research ,National Institute ,Kidney Diseases ,Antibody Detection ,Chief Technical Officer ,Genable Biosciences ,Comprehensive Quality System ,Analytical Validation ,Enable Biosciences Inc ,